A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...

A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...

So, the UK government is considering reclassing ketamine as a Class A drug. The Home Office asked the Advisory Council on the ...

A massive drug bust in Flushing, Queens has led to the indictment of four individuals accused of running a dangerous ...

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

A clinic in Arapahoe County is exploring new ways to help patients by offering ketamine-assisted psychotherapy.

Medicare does not typically cover ketamine infusions for mental health conditions. However, it may cover Spravato, an FDA-approved drug deriving from ketamine, for treatment-resistant depression.

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment isn’t ...